Hatchtech announce successful End-of-Phase 2 for head lice product DeOvo™

03 September 2012

You may also like

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

27 May 2017

OneVentures makes first investment for the Biomedical Translation Fund

24 March 2014

charmhealth names Gary Lakin as new CEO

29 January 2014

Scale Investment in Paloma

27 November 2012

Hatchtech publish data on Head Lice treatment safety study and mechanism of action

13 August 2018

OneVentures invests in regional Queensland company developing treatments for autoimmune diseases

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor
clear Close